AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India · Delayed Price · Currency is INR 7,942.00
-148.00 (-1.83%)
Aug 11, 2026, 3:30 PM IST
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 201.93 billion as of August 11, 2026. Its market cap has decreased by -7.85% in one year.
Market Cap
201.93B
Enterprise Value
198.56B
Revenue
24.30B
Ranking
n/a
PE Ratio
119.05
Stock Price
7,942.00
ChartMarket Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 201.93B, an increase of 13,826.38%. That is a compound annual growth rate of 22.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 201.93B | -10.35% |
| Dec 31, 2025 | 225.25B | 23.26% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 427.69B |
| Emcure Pharmaceuticals | 378.27B |
| Wockhardt | 313.80B |
| Piramal Pharma | 283.50B |
| Eris Lifesciences | 193.08B |
| Cohance Lifesciences | 171.01B |
| Alivus Life Sciences | 168.71B |
| Alembic Pharmaceuticals | 163.41B |